Application 203925
- Type
- ANDA
- Sponsor
- SUN PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RISEDRONATE SODIUM | RISEDRONATE SODIUM | TABLET, DELAYED RELEASE;ORAL | 35MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16714-870 | Risedronate Sodium | Risedronate Sodium | NorthStar RxLLC | ANDA | Current |
| 16714-870 | Risedronate Sodium | Risedronate Sodium | NorthStar RxLLC | ANDA | Current |
| 63304-440 | RISEDRONATE SODIUM | RISEDRONATE SODIUM | Sun Pharmaceutical Industires Inc. | ANDA | Current |
| 63304-440 | RISEDRONATE SODIUM | RISEDRONATE SODIUM | Sun Pharmaceutical Industires Inc. | ANDA | Current |